Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (281-290 of 537) with videos related to

Pageof 54
Sort By:
Genes and Immunity|March 25, 2005
Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patientsJ A Gracie, N Koyama, J Murdoch, et al.
Rheumatology (Oxford, England)|October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Arthritis and Rheumatism|March 6, 2013
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritisSabrina R Kapoor, Andrew Filer, Martin A Fitzpatrick, et al.
Plos One|August 31, 2013
MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in miceAshley M Miller, Derek S Gilchrist, Jagtar Nijjar, et al.
Frontiers in Immunology|April 9, 2020
In Human Autoimmunity, a Substantial Component of the B Cell Repertoire Consists of Polyclonal, Barely Mutated IgG<sup>+ve</sup> B CellsGraeme J M Cowan, Katherine Miles, Lorenzo Capitani, et al.
Arthritis Care & Research|March 18, 2015
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled StudyArthur Kavanaugh, Désirée van der Heijde, Anna Beutler, et al.
The Lancet. Rheumatology|January 22, 2024
Pathways driving tendinopathy and enthesitis: siblings or distant cousins in musculoskeletal medicine?Lindsay A N Crowe, Moeed Akbar, Robert-Jan de Vos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivoWei Xq, M Orchardson, J A Gracie, et al.
Rheumatology and Therapy|March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three IndicationsJoseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trialsStefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Pageof 54

Showing results (281-290 of 537) with videos related to

Sort By:
Pageof 54
Genes and Immunity|March 25, 2005
Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patientsJ A Gracie, N Koyama, J Murdoch, et al.
Rheumatology (Oxford, England)|October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Arthritis and Rheumatism|March 6, 2013
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritisSabrina R Kapoor, Andrew Filer, Martin A Fitzpatrick, et al.
Plos One|August 31, 2013
MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in miceAshley M Miller, Derek S Gilchrist, Jagtar Nijjar, et al.
Frontiers in Immunology|April 9, 2020
In Human Autoimmunity, a Substantial Component of the B Cell Repertoire Consists of Polyclonal, Barely Mutated IgG<sup>+ve</sup> B CellsGraeme J M Cowan, Katherine Miles, Lorenzo Capitani, et al.
Arthritis Care & Research|March 18, 2015
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled StudyArthur Kavanaugh, Désirée van der Heijde, Anna Beutler, et al.
The Lancet. Rheumatology|January 22, 2024
Pathways driving tendinopathy and enthesitis: siblings or distant cousins in musculoskeletal medicine?Lindsay A N Crowe, Moeed Akbar, Robert-Jan de Vos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivoWei Xq, M Orchardson, J A Gracie, et al.
Rheumatology and Therapy|March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three IndicationsJoseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trialsStefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Pageof 54